Virginie Bubien
Virginie Bubien is an expert in Genetics at Institut Bergonié (France). Virginie Bubien has authored 37 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 80 (community average: 125). How the SLR is computed.
LeadR Profile
Genetics
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 37
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma. PMID 42060275 — genes, melanoma, prevalence, eye diseases, uveal melanoma | JAMA Ophthalmol | 2026 | 0 |
| Classification of germline non-truncating variants: a new approach to interpretation. PMID 39358013 — molecular biology, classification, phosphoric monoester hydrolases | J Med Genet | 2024 | 0 |
| Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants. PMID 38060262 — breast neoplasms, melanoma, neoplasms, breast, uveal melanoma | J Natl Cancer Inst | 2023 | 13 |
| Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature. PMID 37442961 — hamartoma syndrome, multiple, diagnosis, dna, neoplasms, genomics, blood, leukocytes, papilloma, mosaicism | BMC Med Genomics | 2023 | 7 |
| Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition. PMID 35017683 — incidence, research design, genetic testing, ovarian neoplasms, genes, hereditary breast and ovarian cancer syndrome, high-throughput nucleotide sequencing | J Hum Genet | 2022 | 3 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Risk reducing Strategies Including Fimbriectomy in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer NCT06726330 — sterilization, menopause, premature, surgical procedures, operative, genetic predisposition to disease, ovary, cardiovascular diseases, neoplasms, cognitive dysfunction, sterilization, tubal, germ-line mutation, osteoporosis, ovarian neoplasms, patient preference, prophylactic surgical procedures, menopause, tissues, genes, brca1, salpingo-oophorectomy, mutation, pelvic neoplasms, fallopian tubes, ovariectomy, carcinoma, women | N/A | Not yet recruiting | 2027 |
LeadR Networks
Main global connection map